ci 934 has been researched along with warfarin in 1 studies
| Studies (ci 934) | Trials (ci 934) | Recent Studies (post-2010) (ci 934) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
|---|---|---|---|---|---|
| 33 | 0 | 2 | 36,573 | 2,143 | 14,728 |
| Protein | Taxonomy | ci 934 (IC50) | warfarin (IC50) |
|---|---|---|---|
| Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grenier, P; Klastersky, J; van der Auwera, P; Vandermies, A | 1 |
1 other study(ies) available for ci 934 and warfarin
| Article | Year |
|---|---|
Comparative in vitro activity of CI934, a new fluoroquinolone, alone and in combination with coumermycin, against gram-positive bacteria.
Topics: Aminocoumarins; Anti-Bacterial Agents; Coumarins; Drug Synergism; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Oxacillin; Quinolines | 1987 |